Notice Announcing FAQ Page and Pre-Application Webinar for RFA-OD-15-006, "Abuse Liability Associated with Reduced Nicotine Content Tobacco Products (R01)"

Notice Number: NOT-OD-15-151

Key Dates
Release Date: September 4, 2015

Related Announcements
RFA-OD-15-006

Issued by
National Institutes of Health (NIH)

Purpose

On August 25, 2015, NIH issued the Funding Opportunity Announcement (FOA) RFA-OD-15-006 "Abuse Liability Associated with Reduced Nicotine Content Tobacco Products (R01)".

To assist potential applicants to the above-referenced FOA, this Notice provides the following information:
1. A Frequently Asked Questions (FAQ) page is available to prospective applicants.
2 An Applicant Information Webinar will be provided on September 21, 2015.

FAQs page:
As a result of discussions with potential applicants, NIH has provided a list of Frequently Asked Questions (FAQs) and answers. The FAQs for this FOA can be found at: https://prevention.nih.gov/docs/trsp/foa/faq-RFA-OD-15-006.pdf. This information may be updated without additional notice. In addition to the FAQs, NIH staff will also respond to questions submitted by potential applicants who contact the staff listed in the FOA under the Agency Contacts section.

Applicant Information Webinar
An Applicant Information Webinar will be held September 21, 2015 1:00 p.m. to 2:30 p.m. (Eastern Time) to provide information about the FOA to prospective applicants. NIH and FDA staff will provide an overview of the FOA and the application review process and answer questions from prospective applicants. The webinar is open to all prospective applicants, but participation in the webinar is not a prerequisite to applying. Information about how to participate in the webinar will be posted here: https://prevention.nih.gov/tobacco-regulatory-science-program/funding-opportunities/webinar-rfa-od-15-006.

Afterwards, the webinar slides will be posted on the same site.

Inquiries

Tobacco Regulatory Science Program (TRSP)
Office of Disease Prevention
Telephone: 301-4517464
Email: [email protected]